If you liked this article you might like

EQT Midstream Partners, AbbVie, Blackstone Group: 'Mad Money' Lightning Round
Here's Why You Should Hope For Panic: Cramer's 'Mad Money' Recap (Friday 4/21/17)
Johnson & Johnson's Weak Pharma Revenue Could Spell Doom for Rest of Sector
Gilead, Pfizer, AbbVie Win From Lilly's Loss